Progressive hepatobiliary autoimmune diseases and cyclic citrullinated peptide antibodies

被引：0
|
作者：
Bugdaci, Mehmet Sait [1 ,2 ]
Akin, Hakan [2 ]
Danalioglu, Ahmet [2 ]
Senturk, Hakan [2 ]
机构：
[1] Konya Meram Educ & Res Hosp, Dept Gastroenterohepatol, Konya, Germany
[2] Bezmi Alem Vakif Univ, Sch Med, Dept Gastroenterohepatol, Istanbul, Turkey
来源：
TURKISH JOURNAL OF GASTROENTEROLOGY | 2013年 / 24卷 / 05期
关键词：
HEPATITIS;
D O I：
10.4318/tjg.2013.0514
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：460 / 461
页数：2
相关论文
共 50 条
  • [1] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES
    Ahmet, Omma
    Sevinc, Can Sandikci
    Tulay, Omma
    Yasar, Karaaslan
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 48 - 48
  • [2] Anti cyclic citrullinated peptide antibodies (anti-CCP) in rheumatic and autoimmune liver diseases
    Fusconi, M
    Vannini, A
    Frisoni, M
    Cassani, F
    Pappas, G
    Zauli, D
    Bianchi, F
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 142 - 142
  • [3] Anti cyclic citrullinated peptide antibodies in rheumatic and non rheumatic diseases
    Dall Aglio, A. C.
    Vannini, A.
    Fusconi, M.
    Bianchi, F.
    Zauli, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 298 - 299
  • [4] Prognostic significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis
    Montano-Loza, Aldo J.
    Czaja, Albert J.
    Carpenter, Herschel A.
    Piette, Andrea
    Murphy, Daniel
    Shums, Zakera
    Burlingame, Rufus
    Norman, Gary L.
    HEPATOLOGY, 2006, 44 (04) : 638A - 638A
  • [5] Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis
    Montano-Loza, Aldo
    Czaja, Albert J.
    Carpenter, Herschel A.
    Piette, Andrea
    Murphy, Daniel
    Shums, Zakera
    Burlingame, Rufus
    Norman, Gary L.
    AUTOIMMUNITY, 2006, 39 (04) : 341 - 348
  • [6] Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis
    Fusconi, M
    Vannini, A
    Dall'Aglio, AC
    Pappas, G
    Cassani, F
    Ballardini, G
    Frisoni, M
    Grassi, A
    Bianchi, FB
    Zauli, D
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (10) : 951 - 955
  • [7] ANTIBODIES TO CYCLIC CITRULLINATED PEPTIDE AND MODIFIED CITRULLINATED VIMENTIN: A ROLE IN RHEUMATOID ARTHRITIS ASSOCIATED WITH AUTOIMMUNE THYROIDITIS
    Dvorovkin, A.
    Odin, V.
    Inamova, O.
    Tyrenko, V.
    Toporkov, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1153 - 1153
  • [8] Reactivity of antibodies to cyclic citrullinated peptide (CCP) and unmodified peptide in systemic rheumatic diseases.
    Yamasaki, Y
    Akaogi, J
    Narain, S
    Richards, H
    Reeves, W
    Satoh, M
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S523 - S524
  • [9] Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis
    Inui, Naoki
    Enomoto, Noriyuki
    Suda, Takafumi
    Kageyama, Yasunori
    Watanabe, Hiroshi
    Chida, Kingo
    CLINICAL BIOCHEMISTRY, 2008, 41 (13) : 1074 - 1077
  • [10] Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases
    Koga, T.
    Migita, K.
    Miyashita, T.
    Maeda, Y.
    Nakamura, M.
    Abiru, S.
    Myoji, M.
    Komori, A.
    Yano, K.
    Yatsuhashi, H.
    Eguchi, K.
    Ishibashi, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : 121 - 124
12345